Colgate-Palmolive Reaffirms 2026 Sales Outlook Despite Weak North America Demand 
WestJet Cancels 86 Flights as CUPE Strike Threat Disrupts Travel 
Samsung Q2 Profit Surges on AI Memory Chip Demand, Forecasts Strong Second Half 
SpaceX Wins $1.6 Billion U.S. Space Force Launch Contracts for Falcon 9 Missions Through 2027 
Japan Earthquake Disrupts Auto and Chip Supply Chains 
Toyota First-Half Global Sales and Production Decline on Weak China Demand, RAV4 Transition 
Microsoft Stock Jumps as Azure Growth, AI Revenue Beat Expectations 
Meta-backed research finds exposure to ‘untrustworthy’ social media is rare. The fine print is less reassuring 
Sony Raises Full-Year Outlook After Q1 Profit Jumps 40% on Gaming and Chip Growth 
T-Mobile Executives Reportedly Oppose $300 Billion Deutsche Telekom Merger 
World game at war: why some European nations have threatened a World Cup boycott 
Meta Stock Drops After Earnings Miss as AI Spending and Legal Costs Weigh on Profit 
Amazon Q2 Earnings Beat Estimates as AWS AI Growth Surges, But Q3 Revenue Forecast Disappoints 
Anthropic Reveals Claude AI Accessed Real Production Systems During Cybersecurity Tests 
Same sparkle, different story: how lab-grown diamonds are transforming the market 
Starbucks Stock Jumps as Q3 Earnings Beat, Sales Growth Drives Higher 2026 Outlook 
Capital One Says AML Review Led to Closure of Trump Organization Accounts 
MOORESTOWN, N.J., April 23, 2018 -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), a healthcare technology company that develops and employs medication risk mitigation software solutions and tools to optimize medication safety, will release its first quarter 2018 operating results on Tuesday, May 8, 2018 after market close, on the investor relations section of TRHC’s website at ir.trhc.com with a conference call hosted by Chairman and CEO, Calvin Knowlton, Ph.D., President, Orsula Knowlton, PharmD, MBA, and Chief Financial Officer, Brian Adams to follow at 5:00 p.m. EDT.
Stockholders and interested participants may listen to a live broadcast of the conference call by dialing 844-413-0947 or 216-562-0423 for international callers, and referencing participant code 1578756 approximately 15 minutes prior to the call. A live webcast of the conference call will be available on the investor relations section of TRHC’s website (ir.trhc.com) and an audio file of the call will also be archived and available for replay approximately two hours after the live event for a period of 90 days thereafter at ir.trhc.com. After the conference call, a replay will be available until May 15, 2018 and can be accessed by dialing 855-859-2056 or 404-537-3406 for international callers, and referencing participant code 1578756.
About Tabula Rasa HealthCare
Tabula Rasa HealthCare (NASDAQ:TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. Medication risk management is TRHC’s lead offering, and its cloud-based software applications provide solutions for a range of payers, providers and other healthcare organizations. For more information, visit: www.TRHC.com.
Contact:
Investors
Bob East or Asher Dewhurst
Westwicke Partners
443-213-0500
[email protected]
Media
Dianne Semingson
[email protected]
215-870-0829
